Clik here to view.
Cross Protection by Encephalitis Vaccine as a Factor for Lesser COVID...
TOKYO A significant discrepancy in mortality among even geographically close regions could be explained by a cross protection induced by Japanese Encephalitis Vaccine (JEV) and/or Tick-Borne...
View ArticleClik here to view.
Takeda Continues Divestiture Strategy with Sale of Select OTC and Non-Core...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select non-core over-the-counter...
View ArticleClik here to view.
BIO KOREA 2020 International Convention to Go Virtual
CHEONGJU, South Korea BIO KOREA 2020 International Convention, where global bio experts correspond, is shifting to an online-only event. This press release features multimedia. View the full release...
View ArticleClik here to view.
Opentrons与Zymo Research合作提供平价的自动化COVID-19检测平台
纽约州布鲁克林 (美国商业资讯)–总部位于加州的生命科学试剂公司Zymo Research Corp与平价易用实验室机器人制造商Opentrons Labworks, Inc合作研制了一款用于SARS-CoV-2分子检测的强大引擎。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20200424005142/zh-CN/...
View ArticleClik here to view.
オープントロンズが廉価な自動化COVID-19検査プラットフォームの提供でザイモリサーチと提携
米ニューヨーク州ブルックリン （ビジネスワイヤ） — カリフォルニアを拠点とする企業としてライフサイエンス研究用試薬を手掛けるザイモリサーチ・コープと、廉価で使いやすいラボ用ロボットのメーカーであるオープントロンズ・ラボワークスは、SARS-CoV-2分子検査用のロバストなエンジンを創出すべく提携しました。...
View ArticleClik here to view.
脳炎ワクチンによる交叉防御能が一部地域における低いCOVID-19死亡率の要因
東京 （ビジネスワイヤ） — 江戸川病院の院長を務める加藤正二郎医師によれば、地理的に近接した地域でさえ死亡率に大きな乖離があることは、日本脳炎ワクチン（JEV）もしくはダニ媒介脳炎（TEV）または両者によって誘導された交叉防御能で説明できるかもしれません。加藤医師とEdogawa Evolutionary Lab of Science（EELS）の国際研究者チームは、査読誌のArchives...
View ArticleClik here to view.
脑炎疫苗的交叉保护是部分地区新冠肺炎死亡率较低的因素
东京 (美国商业资讯)–江户川病院院长Shojiro Katoh博士认为，地域相近地区的死亡率有显著差异，原因可能是日本脑炎疫苗(JEV)和/或Tick-Borne脑炎疫苗(TEV)诱导的交叉保护。他与江户川进化科学实验室(EELS)的国际研究人员团队一道，在同行评议期刊《学术急诊医学杂志》(Archives of Academic Emergency...
View ArticleClik here to view.
Best’s Commentary: COVID-19 Impacts Add to Deterioration in Underwriting...
SINGAPORE For the first time in a decade, the domestic non-life insurance segment in Singapore recorded an underwriting loss in 2019, and with the added economic strain from the COVID-19 pandemic,...
View ArticleAVITA Medical Reports Third Quarter Fiscal 2020 Financial Results and Company...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in...
View ArticleClik here to view.
Study Finds Noninvasive, Continuous Masimo PVi® Monitoring More Valuable Than...
NEUCHATEL, Switzerland Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of Anesthesiology and Reanimation Specialists’ Society in which researchers compared two...
View ArticleClik here to view.
手術中における輸液管理の指針として非侵襲的・連続的Masimo PVi®モニタリングが中心静脈圧測定よりも有益であることを示す研究
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、Journal of Anesthesiology and Reanimation Specialists’ Society誌に掲載された研究結果を発表しました。研究では、研究者らが、Masimo...
View ArticleClik here to view.
Royal Flying Doctor Service and Rio Tinto partner to improve remote and rural...
MELBOURNE, Australia The Royal Flying Doctor Service (Queensland Section) and Rio Tinto have formed a new partnership to improve emergency and remotely delivered health care services across regional...
View ArticleClik here to view.
研究发现，无创连续Masimo PVi®监测对指导术中体液处治的价值优于中央静脉压测量
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天宣布了《麻醉与复苏专家学会杂志》发表的一项研究结果，该研究的研究人员比较脊柱骨科手术中两种体液处治方法，包括Masimo PVi®。与有创间歇性中心静脉压(CVP)测量相比，无创连续脉搏灌注变异指数(PVi)监测时“心脏更稳定、补液更少、血管容积状况的评估结果更精准。”1 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Dr. Reddy’s to release Q4 and full year FY 20 results on May 20, 2020
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) will announce results for the fourth quarter and full year ended March 31, 2020 on Wednesday, May 20, 2020 after...
View ArticleClik here to view.
HighTide Therapeutics Announces Positive Topline Results From Phase 2a Study...
SHENZHEN, China & ROCKVILLE, Md. HighTide Therapeutics Inc. (“HighTide”), a clinical-stage biopharmaceutical company, today announced topline results of the study of HTD1801 in 100 adults with...
View ArticleClik here to view.
AVITA Medical Limited Proposed redomiciliation to the United States of...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical Limited (Company) (ASX:AVH, NASDAQ:RCEL) is pleased to announce that the Federal Court of Australia (Court) has today approved orders to...
View ArticleClik here to view.
Nursing the World to Health: Celebrating Fresenius Kidney Care Nurses’...
HONG KONG Today, on International Nurses Day, Fresenius Medical Care, the world’s leading provider of dialysis products and services, is celebrating the extraordinary contribution that its nurses...
View ArticleClik here to view.
可杀灭 Covid-19的Violeds技术已成功应用于去除异味、杀菌消毒的清洁洗涤
韩国 安山 (美国商业资讯)–首尔伟傲世(代表理事李永柱)(KOSDAQ: 092190)表明，可应用于清洁洗衣的Violeds UVC LED 产品已批量生产，并向中国两大制造商海信(Hisense)和海尔(Haier)供应。海信和海尔是中国家用洗衣机领域的知名企业。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
COVID-19 Sterilizing Violeds Technology Succeeded in Perfect Clean Washing...
ANSAN, South Korea Seoul Viosys (KOSDAQ: 092190), the world’s first compound semiconductor for short wavelength solutions provider, announced that products with Violeds technology for perfectly...
View ArticleClik here to view.
Legend Biotech and Noile-Immune Biotech Announce Collaborative Research and...
SOMERSET, N.J., USA and TOKYO, Japan Legend Biotech Corporation (“Legend”), a global clinical stage biopharmaceutical company engaged in the discovery and development of novel cell therapies,...
View Article